Merck (MRK) Q1 2024 Earnings Call Transcript

MRK earnings call for the period ending March 31, 2024.

Related Keywords

United States , Japan , Chicago , Illinois , China , Argentina , America , American , Argentine , Chris Schott , Seamus Fernandez , James Shin , Carter Gould , Seamus Fernandez Guggenheim , Terence Flynn Morgan Stanley , Daina Graybosch , Chris Shibutani Goldman Sachs , Chris Schott Jpmorgan , Terence Flynn , Caroline Litchfield , Luisa Hector , Carter Gould Barclays , Rob Davis , Trung Huynh , Louise Chen Cantor Fitzgerald , Daiichi Sankyo Adcs , Evan Seigerman , Evan Siegerman , Tim Anderson , Peter Dannenbaum , Asia Pacific , Daina Graybosch Leerink , Daiichi Sankyo , Luisa Hector Berenberg , Louise Chen , Chris Shibutani , European Commission , International Agency For Research On Cancer , Animal Health , Morgan Stanley , Wolfe Research , International Society Of Pneumonia , Tim Anderson Wolfe Research Analyst , James Shin Deutsche Bank Analyst , Advisory Committee On Immunization Practices , European Medicines Agency , Merck Co , Centers Of Excellence , Deutsche Bank , Goldman Sachs , Merck Research Labs , Our Human Health , Company Analyst , Institute Butantan , Zenith , Barclays , Urogen Congress , American Cancer Society , Vice President , Merck Research , Securities Litigation Reform Act , Chief Executive , Wind River , Human Health , Light Spark , Harpoon Therapeutics , International Society , Pneumococcal Diseases , Immunization Practices , International Agency , Sub Saharan Africa , South America , Southeast Asia , Umer Raffat , American Cancer , Capital Markets , Leerink Partners , Cantor Fitzgerald ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.